2022 New York City World TB Day Webinar

Date: March 18, 2022
Time: 12:00 - 4:00 pm Eastern
Location: Online

COURSE HANDOUTS

• Agenda
• Continuing Education Information
• TB in New York City - Joe Burzynski, MD
• CDC Guidelines Updates
• We are TB: Peer Support Services for Patients
• TB Vaccine Development: Lessons from the COVID-19 Pandemic
• Shorter TB Treatment Regimens
• New York City TB Resources

COURSE DESCRIPTION & OVERALL GOAL
This virtual conference will address the TB prevention and elimination efforts in New York City, in the United States, and across the globe. Topics will include an overview of current TB vaccine candidates and new drugs/regimens in the pipeline, the role of patients for TB advocacy and peer support, and the impact of COVID-19 on TB prevention and control globally and in the United States.

WHO SHOULD ATTEND
The webinar is open to physicians, nurses, public health staff, and other health care workers who manage patients at risk for or diagnosed with TB infection or disease.

WHY COURSE IS NEEDED
The COVID-19 pandemic has posed significant challenges to the provision of TB care. Awareness of local and global TB epidemiology and a strong understanding of the long-term impacts of the COVID-19 pandemic are essential to address TB prevention and control needs in the future. TB mortality rates have increased due to reduced access to care, ongoing training and education are important for clinicians so they can develop and enhance skills in the diagnosis of TB, follow recommended treatment guidelines, and interact effectively with public health agencies. This educational activity will provide TB providers and programs with updates of the local and global status of TB control and discuss opportunities to strengthen pandemic response efforts in the future.

LEARNING OBJECTIVES

Upon completion of this activity, participants should be better able:

• Recognize the epidemiology of tuberculosis in New York City to make informed decisions about outreach interventions and allocation of resources.
• Outline strategies to mitigate the potential long-term impacts of the COVID-19 pandemic on TB control programs.
• Discuss the implementation of shorter TB treatment regimens, including increased adherence and decreased loss to follow-up.
• Identify access to TB care is a health equity issue and explore public health strategies for reducing inequities.
• Compare the rapid advances made in the development of effective vaccines for COVID-19 with current research on TB vaccines.  

COURSE REQUIREMENTS
In order to meet the learning objectives and receive continuing education credits, participants are required to attend the webinar and complete an evaluation.

CONTINUING EDUCATION INFORMATION
In support of improving patient care, this activity has been planned and implemented by Rutgers Biomedical and Health Sciences and the New York City Department of Health and Mental Hygiene. Rutgers Biomedical and Health Sciences is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
CME: Rutgers Biomedical and Health Sciences designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
CNE: This activity is awarded 2.0 ANCC contact hours. Nurses should only claim those contact hours actually spent participating in the activity.

REGISTRATION INFORMATION
There is no charge to attend this webinar but pre-registration is mandatory.

Please click here to register. Applicants will receive notification of their confirmation via email.

For additional information, please contact Shwata Suresh Kumar at ss2980@rutgers.edu.

FUNDING DISCLOSURE
Funding for this course was made possible in part by the Centers for Disease Control and Prevention. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services, nor does the mention of trade names, commercial practices, or organizations imply endorsement by the U.S. government.